TVTX- Travere Therapeutics, Inc.

TVTX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Dube Eric M	432.9K	$26.07M	-
Other	Heerma Peter	138.6K	$8.35M	-
Other	Rote William E.	123.1K	$7.41M	-
CFO	Cline Christopher R.	116.9K	$7.04M	-
Other	Inrig Jula	111.5K	$6.71M	-

Buys and sells only

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 23, 2024	Calvin Sandra60	SVP, Chief Accounting Officer	Sell	910	$9.07	$8,252.24	-2.2%	-37.0%	+109.5%
Jan 23, 2024	Heerma Peter53	Chief Commercial Officer	Sell	1,559	$9.07	$14,137.64	-1.9%	-37.0%	+109.5%
Jan 4, 2024	Inrig Jula	Chief Medical Officer	Sell	2,509	$9.43	$23,647.68	-3.4%	-23.2%	+107.5%
Oct 3, 2023	Heerma Peter53	Chief Commercial Officer	Sell	3,091	$8.25	$25,504.15	-3.7%	+11.8%	+62.2%
Sep 5, 2023	Cline Christopher R.48	Chief Financial Officer	Sell	457	$14.71	$6,722.56	-0.9%	-55.7%	-29.2%
Sep 5, 2023	Reed Elizabeth E57	SVP, GC &Corporate Secretary	Sell	1,815	$14.71	$26,698.65	-3.0%	-55.7%	-29.2%
Sep 5, 2023	Dube Eric M56	Chief Executive Officer	Sell	4,455	$14.71	$65,533.05	-1.8%	-55.7%	-29.2%
Sep 5, 2023	Rote William E.58	Senior Vice President, R&D	Sell	1,815	$14.71	$26,698.65	-2.9%	-55.7%	-29.2%
May 11, 2023	Calvin Sandra60	SVP, Chief Accounting Officer	Sell	558	$16.49	$9,199.88	-0.7%	-5.6%	-61.0%
May 10, 2023	Cline Christopher R.48	Chief Financial Officer	Sell	455	$16.59	$7,548.45	-0.9%	-4.8%	-59.5%